C. Camps

Publication List Details

Period

1990 - 2007

Number

145

Co-Authors

Available on CMS information server CMS NOTE 1997/063 The Compact Muon Solenoid Experiment (2007)

S. Bachmann, F. Beiel, C. Camps, V. Commichau, G. Flugge, K. Hangarter, ...

Beam test performance of a closed microstrip gas chamber module for the CMS forward tracker

Cosmic-ray positron fraction measurement from 1 to 30 GeV with AMS-01 (2007)

Aguilar, M, Alcaraz, J, Allaby, James V, Alpat, B, Ambrosi, G, Anderhub, H, ...

A measurement of the cosmic ray positron fraction e+/(e+ + e-) in the energy range of 1-30 GeV is presented. The measurement is based on data taken by the AMS-01 experiment during its 10 day Space...

Cosmic-ray positron fraction measurement from 1 to 30 GeV with AMS-01 (2007)

Aguilar, M., Alcaraz, J., Allaby, J., Alpat, B., Ambrosi, G., Anderhub, H., ...

A measurement of the cosmic ray positron fraction $e^{+}/(e^{+}+e^{−})$ in the energy range of 1–30 GeV is presented. The measurement is based on data taken by the AMS-01 experiment during its...

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients (2006)

Sanchez-Ronco, M., Alberola, V., Taron, M., Camps, C., Garcia-Carbonero, R., ...

Background: Impaired DNA repair capacity may favorably affect survival in cisplatin/gemcitabine-treated non-small-cell lung cancer (NSCLC) patients. We investigated the association of survival with...

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients (2006)

Sanchez-Ronco, M., Alberola, V., Taron, M., Camps, C., Garcia-Carbonero, R., ...

Background: Impaired DNA repair capacity may favorably affect survival in cisplatin/gemcitabine-treated non-small-cell lung cancer (NSCLC) patients. We investigated the association of survival with...

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial (2006)

Camps, C., Massuti, B., Jiménez, A., Maestu, I., Gómez, R. García, Isla, D., ...

Background: Docetaxel is a widely accepted second-line treatment in advanced non-small-cell lung cancer (NSCLC) with a risk of myelotoxicity. This study evaluated the efficacy and toxicity profile of...

Pharmacogenomics and gemcitabine (2006)

Rosell, R., Cobo, M., Isla, D., Camps, C., Massuti, B.

Approximately half of lung cancer patients present with metastases, and a large proportion will develop recurrent disease, with median survival to cisplatin-based chemotherapy of 11 months. No...

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients (2006)

Sanchez-Ronco, M., Alberola, V., Taron, M., Camps, C., Garcia-Carbonero, R., ...

Background: Impaired DNA repair capacity may favorably affect survival in cisplatin/gemcitabine-treated non-small-cell lung cancer (NSCLC) patients. We investigated the association of survival with...

A Study of cosmic ray secondaries induced by the Mir Space Station using AMS-01 (2005)

Aguilar, M., Alcaraz, J., Allaby, J., Alpat, B., Ambrosi, G., Anderhub, H., ...

The Alpha Magnetic Spectrometer (AMS-02) is a high energy particle physics experiment that will study cosmic rays in the $\sim 100 \mathrm{MeV}$ to $1 \mathrm{TeV}$ range and will be installed on the...

Protons in near earth orbit (2005)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The proton spectrum in the kinetic energy range 0.1 to 200 GeV was measured by the Alpha Magnetic Spectrometer (AMS) during space shuttle flight STS-91 at an altitude of 380km. Above the geomagnetic...

Search for antihelium in cosmic rays (2005)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The Alpha Magnetic Spectrometer (AMS) was flown on the space shuttle Discovery during flight STS-91 in a 51.7 degree orbit at altitudes between 320 and 390 km. A total of 2.86 * 10^6 helium nuclei...

Search for antihelium in cosmic rays (2005)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The Alpha Magnetic Spectrometer (AMS) was flown on the space shuttle Discovery during flight STS-91 in a 51.7 degree orbit at altitudes between 320 and 390 km. A total of 2.86 * 10^6 helium nuclei...

Protons in near earth orbit (2005)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The proton spectrum in the kinetic energy range 0.1 to 200 GeV was measured by the Alpha Magnetic Spectrometer (AMS) during space shuttle flight STS-91 at an altitude of 380km. Above the geomagnetic...

Search for antihelium in cosmic rays (2005)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The Alpha Magnetic Spectrometer (AMS) was flown on the space shuttle Discovery during flight STS-91 in a 51.7 degree orbit at altitudes between 320 and 390 km. A total of 2.86 * 10^6 helium nuclei...

Protons in near earth orbit (2005)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The proton spectrum in the kinetic energy range 0.1 to 200 GeV was measured by the Alpha Magnetic Spectrometer (AMS) during space shuttle flight STS-91 at an altitude of 380km. Above the geomagnetic...

A Study of cosmic ray secondaries induced by the Mir Space Station using AMS-01 (2005)

Aguilar, M., Alcaraz, J., Allaby, J., Alpat, B., Ambrosi, G., Anderhub, H., ...

The Alpha Magnetic Spectrometer (AMS-02) is a high energy particle physics experiment that will study cosmic rays in the $\sim 100 \mathrm{MeV}$ to $1 \mathrm{TeV}$ range and will be installed on the...

A Study of cosmic ray secondaries induced by the Mir Space Station using AMS-01 (2005)

Aguilar, M., Alcaraz, J., Allaby, J., Alpat, B., Ambrosi, G., Anderhub, H., ...

The Alpha Magnetic Spectrometer (AMS-02) is a high energy particle physics experiment that will study cosmic rays in the $\sim 100 \mathrm{MeV}$ to $1 \mathrm{TeV}$ range and will be installed on the...

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients (2005)

Cortes-Funes, H., Gomez, C., Rosell, R., Valero, P., Garcia-Giron, C., Velasco, A., ...

Background:: North American and Japanese non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) activation via tyrosine kinase (TK) mutations respond dramatically to...

Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer (2005)

Camps, C., Felip, E., Sanchez, J. M., Massuti, B., Artal, A., Paz-Ares, L., ...

Background: The purpose of this study was to evaluate the tolerability and efficacy of BMS-184476, an analog of paclitaxel, in patients with advanced non-small-cell lung cancer (NSCLC) progressing or...

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer (2004)

Isla, D., Sarries, C., Rosell, R., Alonso, G., Domine, M., Taron, M., ...

Background: Platinum-based doublets are the standard chemotherapy for advanced non-small-cell lung cancer (NSCLC). Excision-repair cross-complementing 1 (ERCC1), xeroderma pigmentosum group D (XPD)...

Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study (2004)

Pico, C., Martin, M., Jara, C., Barnadas, A., Pelegri, A., Balil, A., ...

Background: A prospective randomized clinical trial was implemented to assess whether the concomitant or the sequential addition of tamoxifen to chemotherapy provides improved clinical benefit in the...

The Alpha Magnetic Spectrometer (AMS) (2002)

Alcaraz, J., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., Arefiev, A., ...

The Alpha Magnetic Spectrometer (AMS) is a large acceptance (0.65 sr m(2)) detector designed to operate in the International Space Station (ISS) for three years. The purposes of the experiment are to...

CMS Forward-Backward MSGC milestone (2000)

Bouhali, O, Bachmann, S, Barthe, S, Beaumont, W, Beckers, T, Beissel, F, ...

The CMS MF1 milestone was set in order to evaluate system aspects of the CMS forward-backward MSGC tracker, to check the design and feasibility of mass production and to set up assembly and test...

Protons in near earth orbit (2000)

Alcaraz, J, Alvisi, D, Alpat, B, Ambrosi, G, Anderhub, H, Ao, L, ...

The proton spectrum in the kinetic energy range 0.1 to 200 GeV was measuredby the Alpha Magnetic Spectrometer (AMS) during space shuttle flight STS-91 atan altitude of 380 km. Above the geomagnetic...

Protons in near earth orbit (2000)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The proton spectrum in the kinetic energy range 0.1 to 200 GeV was measured by the Alpha Magnetic Spectrometer (AMS) during space shuttle flight STS-91 at an altitude of 380km. Above the geomagnetic...

Protons in near earth orbit (2000)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The proton spectrum in the kinetic energy range 0.1 to 200 GeV was measured by the Alpha Magnetic Spectrometer (AMS) during space shuttle flight STS-91 at an altitude of 380km. Above the geomagnetic...

Search for antihelium in cosmic rays (1999)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The Alpha Magnetic Spectrometer (AMS) was flown on the space shuttle Discovery during flight STS-91 in a 51.7 degree orbit at altitudes between 320 and 390 km. A total of 2.86 * 10^6 helium nuclei...

Search for antihelium in cosmic rays (1999)

Alcaraz, J., Alvisi, D., Alpat, B., Ambrosi, G., Anderhub, H., Ao, L., ...

The Alpha Magnetic Spectrometer (AMS) was flown on the space shuttle Discovery during flight STS-91 in a 51.7 degree orbit at altitudes between 320 and 390 km. A total of 2.86 * 10^6 helium nuclei...

Construction, test and operation in a high intensity beam of a small system of microstrip gas chambers (1997)

Barr, A J, Bachmann, S, Boimska, B, Bouclier, Roger, Braem, André, Camps, C, ...

We describe the construction, test and installation procedures, and the experience gained with the operation of a small but complete system of high rate Micro-Strip Gas Chambers, made on thin...

5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (1993)

Cervantes, A., Villar-Grimalt, A., Abad, A., Antón-Torres, A., Belón, J., Dorta, J., ...

Background: Metastatic disease is a common problem in gastric cancer and the development of better chemotherapeutic regimens is a clear priority in gastrointestinal oncology. Patients and methods:...

Etoposide (E) + epirebicin (E) + cisplatin (P) combination chemotherapy (EEP) In advanced gastric cancer: Negative impact on clinical outcome: on behalf of the Spanish Cooperative Group for GI Tumor Therapy (T.T.D.) (1992)

Díaz-Rubio, E., Jimeno, J., Aranad, E., Massuti, B., Camps, C., Cervantes, A., ...

One hundred nineteen patients with advanced gastric cancer were included in a study comparing EEP vs. FEM chemotherapy. The response rate was higher (30%) in patients on EEP than in those...

Organochlorine in the serum of inhabitants living near an electrochemical factory

Sala, M., Sunyer, J., Otero, R., Santiago-Silva, M., Camps, C., Grimalt, J.

OBJECTIVES: To measure the impact of occupational and lifestyle factors on concentrations of organochlorine compounds in a general population sample living near an electrochemical factory with a high...